# Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer

> clinical trial · VERIFIED · 2026-07-10

Status: WITHDRAWN · Sponsor: Chongqing Precision Biotech Co., Ltd · Condition: Solid Tumor

- Company: Chongqing Precision Biotech Co., Ltd
- Sector: Solid Tumor
- Primary source: https://clinicaltrials.gov/study/NCT04348643

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.